REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 45 filers reported holding REPROS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,000 | 0.0% | 985 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 985 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 985 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 985 | -2.5% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 1,010 | -19.5% | 0.00% | – |
| Q4 2015 | $1,000 | -88.9% | 1,255 | +8.2% | 0.00% | – |
| Q3 2015 | $9,000 | -78.0% | 1,160 | -79.8% | 0.00% | – |
| Q2 2015 | $41,000 | -39.7% | 5,735 | -27.1% | 0.00% | – |
| Q1 2015 | $68,000 | -24.4% | 7,868 | -12.3% | 0.00% | – |
| Q4 2014 | $90,000 | +52.5% | 8,967 | +48.4% | 0.00% | – |
| Q3 2014 | $59,000 | -93.5% | 6,043 | -88.4% | 0.00% | -100.0% |
| Q2 2014 | $904,000 | -13.8% | 52,293 | -11.6% | 0.00% | 0.0% |
| Q1 2014 | $1,049,000 | +0.5% | 59,151 | +3.7% | 0.00% | 0.0% |
| Q4 2013 | $1,044,000 | +52100.0% | 57,031 | +74940.8% | 0.00% | – |
| Q3 2013 | $2,000 | -99.7% | 76 | -99.8% | 0.00% | -100.0% |
| Q2 2013 | $757,000 | – | 41,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |